InvestorsHub Logo
Followers 7
Posts 564
Boards Moderated 2
Alias Born 11/18/2023

Re: None

Sunday, 04/14/2024 2:40:36 PM

Sunday, April 14, 2024 2:40:36 PM

Post# of 9388
Keep your eye on the prize my fellow MindMed shareholders. A company with a similar profile was bought out for $14 billion while still in FDA Phase 3 clinical trials and WITHOUT FDA Breakthrough designation! Know what you own! Stay well my people!
https://www.biopharmadive.com/news/bristol-myers-karuna-acquire-schizophrenia-kar-xt/703313/
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNMD News